The era of big pharma as product-first companies must end, as services become the larger priority.
Kostja Paschalidis
Advertisement
Articles by Kostja Paschalidis
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies
2
Pharma Pulse: Amgen's Uplizna Secures CD19 Approval for Myasthenia Gravis, as Asthma Biologic Switches Highlight Efficacy Expectations Gap
3
Trade & Channel Strategies 2025: Inside Pharma’s Turning Point
4
Working with the Middle
5
